Skip to main content

Advertisement

Table 3 Frequency of DRE and PSA based screening by location of practice and gender for patients aged 40 to 69

From: Prostate cancer screening in Primary Health Care: the current state of affairs

  Every year Every 2 years Every 5 years Would not recommend P value Other/not answered
DRE
Setting      0.194  
Metro GP (%) 25 (34.3) 25 (34.3) 8 (11.0) 15 (20.5) 20
Rural GP 6 (22.2) 8 (29.6) 7 (25.9) 6 (22.2) 28
Gender      0.388  
Female GP (%) 10 (32.3) 12 (38.7) 5 (16.1) 4 (12.9) 12
Male GP (%) 21 (31.3) 19 (28.4) 10 (14.9) 17 (25.4)   35
PSA
Setting      0.006  
Metro GP (%) 35 (49.3) 15 (21.1) 7 (9.9) 14 (19.7) 22
Rural GP (%) 7 (18.4) 14 (36.8) 4 (10.5) 13 (34.2) 17
Gender      0.434  
Female GP (%) 10 (30.3) 9 (27.3) 7 (21.2) 7 (21.2) 10
Male GP (%) 31 (41.9) 19 (25.7) 4 (5.4) 20 (27.0) 28
  1. Percentages and p-values calculated only for subjects that gave a response.